In an Israeli mall located in an unobstructed corridor, it is equivalent to the Nasa mission control in Houston.
There are still no rows of filmmakers and flight controllers wearing headsets, all faces being set in a spacecraft defined on the big screen. Astronauts do not solve the problem.
Instead, it shows a world map satellite on three large computer displays, roughly the size of a large shoebox in the world orbit. There are many private autonomous "space laboratories" that include customer pay-as-you-go experiments, including pharmaceutical companies, universities and chemical companies.
It is a new space exploration and research frontier. The stunning and slowest governing bodies like NASA have no monopoly. The market has been marketed for large-scale aerospace companies, including SpaceX and Boeing, but also plucky startups that use cheaper access to the sky.
Israel, SpacePharma, is trying to deepen the emerging space industry: microgravity experimentation.
At the heart of this process, in order to test probabilities, it is now impossible to repeat the plan: very close to zero gravity or zero gravity. Without gravity, a constantly constant constraint of each experiment, a new field of science is a promising progress.
"In space, everything is different," said Yair Glick, SpacePharma's research and development director. Almost nothing – chemists, plants, and even human cells – make themselves the same as microgravity in the Earth.
The simple experiment also produces new results: "If water mixes oil, we know that water is lowered and oil is not in space," said Glick.
National space organizations have been conducting research for the past ten years, many of them astronauts bones and bones, but other elements, such as flames, do not move upwards but create a ball.
The results are amazed. An experiment by the Japanese Aerospace Exploration Agency examined the Duchenne protein related to muscle distrophy, which affects young men and leaves these movements.
Proteins, the cellular building blocks, crystallize differently in space, because they are pulled from the Earth and are more ordered. Researchers record their new structure and delay the consequences of illness in medicine. Their creators believe they would lead to the duplication of patients' lives and keep them up to 25 years, up to 12.
Rich Godwin is led by US Space Technology Holding, who works in space and applies to the real world market. Commercial microgravity testing is a huge potential market, and expects more success as privatized. "It does not change chemistry. Physics is changing," he said. "It's like the invention of the microscope."
Yossi Yamin, CEO and founder of SpacePharma, calculates private companies that sell 30 microgravure experiments.
There are three ways to do this. The first one can be made on the Earth to rent the plane and divide it in a parabolic flight, simulating weight strength. But the process is very indefinite and only lasts for a few seconds.
Most companies are renting 250 miles in the international space station, which acts as a real estate agent in orbit on the ground. They work on small automated laboratories that enter the gang, often delivered by astronauts and into the wall. In this case, the liquids can be heated, cooled and tiny automatic pumps to allow customers to mix chemicals.
SpacePharma also offers free satellites in the Earth's orbit independently. They were first sent to the Indian 2017 rockets.
In a small office in Herzliya, the city of the Israeli technological center, nanosatelites are handmade, with a plastic 3D printer and a soldering desk. "If you have autonomous mobile units, you can command and control your mobile device," said Yamin, who has been working for the Israeli navy fleet for 25 years.
Each satellite costs about £ 2.4m, but has enough space for 12 clients, which runs the experiments at the same time, significantly reducing the cost. The commercial space research company is worth about half a million, estimates it. But he is betting on a boom in the market.
Pharmaceutical companies are looking to create drugs in the space, more efficient than those on Earth. When more and more complex proteins are produced, "seeds" can be used to duplicate on Earth. "These are masterpieces created in orbit," said Yamin.
The next step in the field of microgravity, according to industry experts, will be "space factories" when materials that are made in space are manufactured.
Twyman Clements, Space Tango's CEO, has begun operating this year's US company, and has experimented over 88 experiments in space, including Budweiser's conspiracy, and another that reacts to cannabis in space. But now it's time to bring products back and forth.
"This is not only for research. It has a scalable application," said Clements, who grew up in a Kentucky farmhouse and made rockets. "We will see high value-added products in Earth Microlitination," he said. They have to have a great price tag, so it costs so much to upload material up and down.
Already customers are used to make fiber optic cables, when they are manufactured in space more efficiently. And other products that can be orbital are retinal implants to recover the vision of proteins to activate light, but do not form on the ground according to their weight. Space Tango explores how space can do.
"The next steps are geared toward production," said Clements. "This has not happened yet. Retinal impacts may be the first."
This article is part of a series of possible solutions to some of the most difficult problems around the world. What else do we cover? Send an email to [email protected]